Phocas Financial Corp’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-102,550
| Closed | -$3.36M | – | 155 |
|
|
2025
Q1 | $3.36M | Sell |
102,550
-5,929
| -5% | -$194K | 0.51% | 82 |
|
|
2024
Q4 | $3.92M | Sell |
108,479
-981
| -0.9% | -$35.5K | 0.52% | 83 |
|
|
2024
Q3 | $3.41K | Sell |
109,460
-6,883
| -6% | -$215 | 0.01% | 119 |
|
|
2024
Q2 | $3.11K | Sell |
116,343
-2,199
| -2% | -$59 | 0.01% | 123 |
|
|
2024
Q1 | $4.04K | Sell |
118,542
-3,017
| -2% | -$103 | 0.02% | 113 |
|
|
2023
Q4 | $3.52M | Sell |
121,559
-35,507
| -23% | -$1.03M | 0.46% | 96 |
|
|
2023
Q3 | $4.33M | Sell |
157,066
-150
| -0.1% | -$4.14K | 0.63% | 73 |
|
|
2023
Q2 | $4.73M | Sell |
157,216
-878
| -0.6% | -$26.4K | 0.65% | 72 |
|
|
2023
Q1 | $5.73M | Sell |
158,094
-16,852
| -10% | -$611K | 0.82% | 49 |
|
|
2022
Q4 | $6.24M | Buy |
174,946
+42,348
| +32% | +$1.51M | 0.9% | 41 |
|
|
2022
Q3 | $4.49M | Buy |
132,598
+26,493
| +25% | +$897K | 0.7% | 65 |
|
|
2022
Q2 | $3.07M | Buy |
+106,105
| New | +$3.07M | 0.46% | 93 |
|